Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro

Journal of the National Cancer Institute

Volumn 88, Issue 3-4, 1996, Pages 198-205

  Vidal Vanaclocha, Fernando ^a   Alvarez, Antonia ^a   Asumendi, Aintzane ^a   Urcelay, Blanca ^a   Tonino, Paola ^a   Dinarello, Charles A ^b,c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 1; MANNOSE RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL ADHESION; HORMONE RECEPTOR INTERACTION; INFLAMMATION; LIVER METASTASIS; MELANOMA; MOUSE; NONHUMAN;

ANIMALS; CELL ADHESION; ENDOTHELIUM, VASCULAR; GROWTH SUBSTANCES; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; LIVER NEOPLASMS; MALE; MANNOSE-BINDING LECTINS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; RECEPTORS, CELL SURFACE; SIALOGLYCOPROTEINS;

EID: 0030056869     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.3-4.198     Document Type: Article

References (53)

1. Nicolson GL. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 1988;7-143-88.
2. Weiss L, Orr FW, Honn KV. Interaction between cancel cells and the microvasculature: a rate-regulator for metastasis. Clim Exp Metastasis 1989;7:127-67.
3. Zetter BR. The cellular basis of site-specific tumor metastasis. N Engl J Med 1990; 322:605-11.
4. Belloni PN, Tressler RJ. Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells. Cancer Metastasis Rev 1990,8:353-89.
5. Rice GE, Bevilacqua MP. An mducible endothehal cell surface glycoprotein mediates melanoma adhesion Science 1989;246:1303-6.
6. Dejana E, Bertocchi F, Bortolami MC. Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. J Clin Invest 1988;82:1466-70.
7. Bereta M, Bereta J, Cohen S, Zaifert K, Cohen MC. Effect of inflammatory cytokines on the adherence of tumor cells to endothelium in a murine model. Cell Immunol 1991;136:263-77.
8. Bertomeu MC, Gallo S, Lauri D, Haas TA, Orr FW, Bastida E, et al. Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression Clin Exp Metastasis 1993;11.243-50.
9. Chirvi RG, Garofalo A, Padura IM, Mantovani A, Giavazzi R. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse model. Cancer Res 1993;53:5051-4.
10. Giavazzi R, Garofalo A, Bani MR, Abbate M, Ghezzi P, Boraschi D, et al. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 1990;50:4771-5.
11. Malik ST, Naylor MS, East N, Oliff A, Balkwill FR. Cells secreting tumour necrosis factor show enhanced metastasis in nude mice. Eur J Cancer 1990;26:1031-4.
12. Argüello F, Baggs RB, Graves BT, Harwell SE, Cohen HJ, Frantz CN. Effect of IL-1 on experimental bone/bone-marrow metastases. Int J Cancer 1992;52:802-7.
13. Bani MR, Garofalo A, Scanziani E, Giavazzi R. Effect of interleukin-1-beta on metastasis formation in different tumor systems. J Natl Cancer Inst 1991;83:119-23.
14. Orosz P, Echtenacher B, Falk W, Ruschoff J, Weber D, Mannel DN. Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med 1993;177:1391-8.
15. Van Den Brenk HA, Stone M, Kelly H, Orton C, Sharpington C. Promotion of growth of tumour cells in acutely inflamed tissues. Br J Cancer 1974;30:246-60.
16. Der Hagopian RP, Sugarbakcr EV, Ketcham A. Inflammatory oncotaxis. JAMA 1978;240: 374-5.
17. Orr FW, Adamson IY, Young L. Pulmonary inflammation generates chemotactic activity for tumor cells and promotes lung metastasis. Am Rev Respir Dis 1985;131.607-11.
18. Dunnington DJ, Buscarino C, Gennaro D, Greig R, Poste G. Characterization of an animal model of metastatic colon carcinoma. Int J Cancer 1987;39:248-54.
19. Lafrenie R, Shaughnessey SG, Orr FW. Cancer cell interactions with injured or activated endothelium. Cancer Metastasis Rev 1992; 11:377-88.
20. Murphy P, Alexander P, Senior PV, Fleming J, Kirkham N, Taylor I. Mechanisms of organ selective tumour growth by bloodborne cancer cells. Br J Cancer 1988;57:19-31.
21. Sugarbaker EV, Weingrad DN, Roseman JM. Observations on cancer metastasis in man. In: Liotta LA, Hart IR, editors. Turmor invasion and metastasis. The Hague: Nijhoff, 1982:427-65.
22. Lee YT. Malignant melanoma: pattern of metastasis. CA Cancer J Clin 1980,30:137-42.
23. de la Monte SM, Moore GW, Hutchins GM. Patterned distribution of metastases from malignant melanoma in humans. Cancer Res 1983;43.3427-33.
24. McCloskey TW, Todaro JA, Laskin DL. Lipopolysaccharide treatment of rats alters antigen expression and oxidative metabolism in hepatic macrophages and endothelial cells. Hepatology 1992;16:191-203.
25. Volpes R, van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules m liver inflammation. Hepatology 1990; 12:59-65.
26. Scoazec JY, Feldmann G. In situ immunophenotyping study of endothelial cells of the human hepatic sinusoid: results and functional implications. Hepatology 1991;14:789-97.
27. Feder LS, McCloskey TW. Laskin DL Characterization of interleukin-1 (IL-1) and interleukin-6 (IL-6) production by resident and lipopolysaccharide (LPS) activated hepatic macrophages and endothelial cells. In: Wisse E, Knook DL, McCuskey RS, editors. Cells of the hepatic sinusoid. Leiden, The Netherlands: Kupffer Cell Foundation, 1991:37-9.
28. Vidal-Vanaclocha F, Amézaga C, Asumendi A, Kaplanski G, Dinarello CA. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 1994;54:2667-72
29. Vidal-Vanaclocha F, Asumendi A, Rocha M, et al. Participation of endothelial cell mannose receptors in the B16 melanoma cell adhesion to the hepatic sinusoidal endothelium. In: Knook D, Wisse E, editors. Cells of the hepatic sinusoid. Leiden, The Netherlands: Kupffer Cell Foundation, 1993:555-8.
30. Asumendi A, Alvarez A, Martínez I, et al. Interleukin-1-dependent stimulation of mannose receptor activity in the hepatic sinusoidal endothelium. In: Knook D, Wisse E, editors. Cells of the hepatic sinusoid. Leiden, The Netherlands: Kupffer Cell Foundation, 1995: 209-11.
31. Barberá-Guillem E, Barceló JR, Urcelay B, Alonso-Varona AI, Vidal-Vanaclocha F. The noncorrelation between implantation and growth of tumor cells for their final metastatic efficiency. Invasion Metastasis 1988;8:266-84.
32. Barbera-Guillem E, Rocha M, Alvarez A, Vidal-Vanaclocha F. Differences in the lectin-binding patterns of the periportal and perivenous endothelial domains in the liver sinusoids. Hepatology 1991;14:131-9.
33. Vidal-Vanaclocha F, Rocha M, Asumendi A, Barberá-Guillem E. Isolation and enrichment of two sublobular compartment-specific endothelial cell subpopulations from liver sinusoids. Hepatology 1993;18:328-39.
34. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J. Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-12.
35. Barberá-Guillem E, Alonso-Varona A, Vidal-Vanaclocha F. Selective implantation and growth in rats and mice of experimental liver metastasis in acinar zone one. Cancer Res 1989;49:4003-10.
36. Ulich TR, Guo KZ, Remick DG, Davatelis GN. Endotoxin-induced cytokine gene expression. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression Am J Pathol 1990;137:1173-85.
37. Antin JH, Weinstein HJ, Guinan EC, McCarthy P, Bierer BE, Gilliland DG, et al. Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease. Blood 1994;84: 1342-8.
38. Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group [see comment citation in Medline]. JAMA 1994;271:1836-43
39. Fisher CJ Jr, Slotman GJ, Opal SM, Pribble JP. Bone RC, Emmanuel G, et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. The IL-1RA Sepsis Syndrome Study Group [see comment citation in Medline]. Crit Care Med 1994,22: 12-21.
40. Barberá-Guillem E, Smith I, Weiss L. Cancer-cell traffic in the liver. II. Arrest, transit and death of B16F10 and M5076 cells in the sinusoids. Int J Cancer 1992;53:298-301.
41. Bouwens L, Jacobs B, Remels L, Wisse E. Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma. Cancer Immunol Immunother 1988;27:137-41.
42. Anasagasti MJ, Avivi C, Vidai-Vanaclocha F. In vitro hydrogen peroxide production by the mouse liver sinusoidal endothelium in response to soluble and melanoma cell surface-associated interleukin-1. In: Knook D, Wisse E, editors. Cells of the hepatic sinusoid. Leiden, The Netherlands: Kupffer Cell Foundation, 1995:204-6.
43. Lauri D, Bertomeu MC, Orr FW. Interleukin-1 increases tumor cell adhesion to endothehal cells through an RDG dependent mechanism: in vitro and in vivo studies. Clin Exp Metastasis 1990;8:27-32.
44. Rice GE, Gimbrone MA Jr, Bevilacqua MP Tumor cell-endothelial interactions. Increased adhesion of human melanoma cells to activated vascular endothelium. Am J Pathol 1988;133:204-10.
45. Vidal-Vanaclocha F, Rocha M, Asumendi A, Barberá-Guillem E. Role of periportal and perivenous sinusoidal endothelial cells in hepatic homing of blood and metastatic cancer cells. Semin Liver Dis 1993;13:60-71.
46. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990;192:245-61.
47. Nicolson GL. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis Exp Cell Res 1993;204:171-80.
48. Reider H, Ramadori G, Meyer Z, et al. The plasma system of sinusoidal endothelial cells in vitro. In: Knook D, Wisse E, editors. Cells of the hepatic sinusoid. Leiden, The Netherlands: Kupffer Cell Foundation, 1993:40-4.
49. Paget S. The distribution of secondary growths in cancer of the breast. 1989 [classical article]. Cancer Metastasis Rev 1989;2:98-101.
50. Bennicelli J, Elias L, Kern J, Guerry D 4th. Production of interleukin 1 activity by cultured human melanoma cells. Cancer Res 1989, 49:930-5.
51. Köck A, Schwarz T, Urbanski A, Peng Z, Vetterlein M, Mieksche M, et al. Expression and release of interleukin-1 by different human cell lines. J Natl Cancer Inst 1989;81:36-42.
52. Burrows FJ, Haskard DO, Hart IR, Marshall JF, Selkirk S, Poole S, et al. Influence of tumor-derived mterleukin 1 on melanoma-endothelial cell interactions in vitro. Cancer Res 1991;51:4768-75.
53. Vidal-Vanaclocha F, Alvarez A, Asumendi A, et al. Juxtacrine activation of liver sinusoidal endothelium by B16 melanoma cell surface-associated IL-1 stimulates on site release of prometastatic factors. In: Knook D, Wisse E, editors. Cells of the hepatic sinusoid. Leiden, The Netherlands: Kupffer Cell Foundation, 1995:119-23.